BIOAGE Labs Inc
NASDAQ:BIOA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BIOAGE Labs Inc
NASDAQ:BIOA
|
US |
|
Rivian Automotive Inc
F:99U
|
US |
Cash Flow Statement
Cash Flow Statement
BIOAGE Labs Inc
| Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
(86)
|
(71)
|
(84)
|
(79)
|
(76)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
7
|
7
|
10
|
11
|
12
|
|
| Other Non-Cash Items |
19
|
8
|
11
|
11
|
12
|
|
| Cash Interest Paid |
2
|
1
|
2
|
1
|
1
|
|
| Change in Working Capital |
3
|
11
|
4
|
10
|
5
|
|
| Cash from Operating Activities |
(63)
N/A
|
(52)
+18%
|
(69)
-34%
|
(57)
+17%
|
(59)
-2%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
(78)
|
(93)
|
(80)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+17%
|
(78)
-21 308%
|
(94)
-20%
|
(81)
+14%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
388
|
392
|
392
|
222
|
28
|
|
| Net Issuance of Debt |
(29)
|
(6)
|
(8)
|
(6)
|
(6)
|
|
| Other |
(4)
|
(5)
|
(5)
|
(4)
|
(1)
|
|
| Cash from Financing Activities |
355
N/A
|
381
+7%
|
380
0%
|
213
-44%
|
20
-90%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
292
N/A
|
329
+13%
|
233
-29%
|
61
-74%
|
(119)
N/A
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(63)
N/A
|
(52)
+18%
|
(70)
-34%
|
(58)
+16%
|
(59)
-1%
|
|